Loading…

Dyskinesia induced by phenytoin

Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia. We investigated the occurrence of involuntary movements in patients followed at our adult and pediatric...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria 1999-06, Vol.57 (2B), p.356-360
Main Authors: Montenegro, M A, Scotoni, A E, Cendes, F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323
cites cdi_FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323
container_end_page 360
container_issue 2B
container_start_page 356
container_title Arquivos de neuro-psiquiatria
container_volume 57
creator Montenegro, M A
Scotoni, A E
Cendes, F
description Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia. We investigated the occurrence of involuntary movements in patients followed at our adult and pediatric epilepsy clinics during the period of one year. Three patients presented with phenytoin-induced dyskinesia: one adult with axial and orofacial dyskinesia, and two children with choreoathetosis. They did not have other signs of phenytoin intoxication and had complete recovery after phenytoin withdrawal. Phenytoin induced dyskinesia may occur during either chronic or initial treatment and with normal serum phenytoin levels. However, it occurs most often in patients on polytherapy, usually after increasing dosage and with toxic serum levels. Other signs of phenytoin intoxication may be present in these patients, but often the dyskinesia is the only side effect, which may delay the diagnosis and treatment. The clinical characteristics of the involuntary movements vary and may be focal or generalized, most often characterized by choreoathetosis and dyskinesias. These may last for hours, days or even years, but frequently disappear completely after phenytoin withdrawal.
doi_str_mv 10.1590/s0004-282x1999000300002
format article
fullrecord <record><control><sourceid>scielo_cross</sourceid><recordid>TN_cdi_scielo_journals_S0004_282X1999000300002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S0004_282X1999000300002</scielo_id><sourcerecordid>S0004_282X1999000300002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323</originalsourceid><addsrcrecordid>eNp9kNtKw0AQhhdRbK2-gs0LpM5mT9lLqVaFghcqeLfsEbe2Sck2YN7ehCjUGy-GmWHmm-H_EZpjWGAm4SYBAM2LsvjCUsq-IX1AcYKmv4P306N6gi5S2vQLVEpxjiYYKANCyima33XpM1Y-RZ3FyrXWu8x02f7DV92hjtUlOgt6m_zVT56ht9X96_IxXz8_PC1v17klUhxyQZ0BzjSADYY7Y6jXMjBblpxSXWLhnZBYMBmAFzgEzAW3pdCeCY49KcgMLca7yUa_rdWmbpuqf6heBhFqEPFHaQ-IEbBNnVLjg9o3caebTmFQg0f_kNcjuW_NzrsjbjSFfAPvnV5t</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dyskinesia induced by phenytoin</title><source>SciELO Brazil</source><creator>Montenegro, M A ; Scotoni, A E ; Cendes, F</creator><creatorcontrib>Montenegro, M A ; Scotoni, A E ; Cendes, F</creatorcontrib><description>Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia. We investigated the occurrence of involuntary movements in patients followed at our adult and pediatric epilepsy clinics during the period of one year. Three patients presented with phenytoin-induced dyskinesia: one adult with axial and orofacial dyskinesia, and two children with choreoathetosis. They did not have other signs of phenytoin intoxication and had complete recovery after phenytoin withdrawal. Phenytoin induced dyskinesia may occur during either chronic or initial treatment and with normal serum phenytoin levels. However, it occurs most often in patients on polytherapy, usually after increasing dosage and with toxic serum levels. Other signs of phenytoin intoxication may be present in these patients, but often the dyskinesia is the only side effect, which may delay the diagnosis and treatment. The clinical characteristics of the involuntary movements vary and may be focal or generalized, most often characterized by choreoathetosis and dyskinesias. These may last for hours, days or even years, but frequently disappear completely after phenytoin withdrawal.</description><identifier>ISSN: 0004-282X</identifier><identifier>ISSN: 1678-4227</identifier><identifier>EISSN: 0004-282X</identifier><identifier>DOI: 10.1590/s0004-282x1999000300002</identifier><identifier>PMID: 10450338</identifier><language>eng</language><publisher>Brazil: Academia Brasileira de Neurologia - ABNEURO</publisher><subject>Anticonvulsants - adverse effects ; Child ; Child, Preschool ; Dyskinesia, Drug-Induced - etiology ; Female ; Humans ; Male ; Middle Aged ; NEUROSCIENCES ; Phenytoin - adverse effects ; PSYCHIATRY</subject><ispartof>Arquivos de neuro-psiquiatria, 1999-06, Vol.57 (2B), p.356-360</ispartof><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323</citedby><cites>FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,24150,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10450338$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montenegro, M A</creatorcontrib><creatorcontrib>Scotoni, A E</creatorcontrib><creatorcontrib>Cendes, F</creatorcontrib><title>Dyskinesia induced by phenytoin</title><title>Arquivos de neuro-psiquiatria</title><addtitle>Arq Neuropsiquiatr</addtitle><description>Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia. We investigated the occurrence of involuntary movements in patients followed at our adult and pediatric epilepsy clinics during the period of one year. Three patients presented with phenytoin-induced dyskinesia: one adult with axial and orofacial dyskinesia, and two children with choreoathetosis. They did not have other signs of phenytoin intoxication and had complete recovery after phenytoin withdrawal. Phenytoin induced dyskinesia may occur during either chronic or initial treatment and with normal serum phenytoin levels. However, it occurs most often in patients on polytherapy, usually after increasing dosage and with toxic serum levels. Other signs of phenytoin intoxication may be present in these patients, but often the dyskinesia is the only side effect, which may delay the diagnosis and treatment. The clinical characteristics of the involuntary movements vary and may be focal or generalized, most often characterized by choreoathetosis and dyskinesias. These may last for hours, days or even years, but frequently disappear completely after phenytoin withdrawal.</description><subject>Anticonvulsants - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dyskinesia, Drug-Induced - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>NEUROSCIENCES</subject><subject>Phenytoin - adverse effects</subject><subject>PSYCHIATRY</subject><issn>0004-282X</issn><issn>1678-4227</issn><issn>0004-282X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp9kNtKw0AQhhdRbK2-gs0LpM5mT9lLqVaFghcqeLfsEbe2Sck2YN7ehCjUGy-GmWHmm-H_EZpjWGAm4SYBAM2LsvjCUsq-IX1AcYKmv4P306N6gi5S2vQLVEpxjiYYKANCyima33XpM1Y-RZ3FyrXWu8x02f7DV92hjtUlOgt6m_zVT56ht9X96_IxXz8_PC1v17klUhxyQZ0BzjSADYY7Y6jXMjBblpxSXWLhnZBYMBmAFzgEzAW3pdCeCY49KcgMLca7yUa_rdWmbpuqf6heBhFqEPFHaQ-IEbBNnVLjg9o3caebTmFQg0f_kNcjuW_NzrsjbjSFfAPvnV5t</recordid><startdate>19990601</startdate><enddate>19990601</enddate><creator>Montenegro, M A</creator><creator>Scotoni, A E</creator><creator>Cendes, F</creator><general>Academia Brasileira de Neurologia - ABNEURO</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>GPN</scope></search><sort><creationdate>19990601</creationdate><title>Dyskinesia induced by phenytoin</title><author>Montenegro, M A ; Scotoni, A E ; Cendes, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anticonvulsants - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dyskinesia, Drug-Induced - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>NEUROSCIENCES</topic><topic>Phenytoin - adverse effects</topic><topic>PSYCHIATRY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montenegro, M A</creatorcontrib><creatorcontrib>Scotoni, A E</creatorcontrib><creatorcontrib>Cendes, F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SciELO</collection><jtitle>Arquivos de neuro-psiquiatria</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montenegro, M A</au><au>Scotoni, A E</au><au>Cendes, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dyskinesia induced by phenytoin</atitle><jtitle>Arquivos de neuro-psiquiatria</jtitle><addtitle>Arq Neuropsiquiatr</addtitle><date>1999-06-01</date><risdate>1999</risdate><volume>57</volume><issue>2B</issue><spage>356</spage><epage>360</epage><pages>356-360</pages><issn>0004-282X</issn><issn>1678-4227</issn><eissn>0004-282X</eissn><abstract>Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. To describe the clinical characteristics of phenytoin induced dyskinesia. We investigated the occurrence of involuntary movements in patients followed at our adult and pediatric epilepsy clinics during the period of one year. Three patients presented with phenytoin-induced dyskinesia: one adult with axial and orofacial dyskinesia, and two children with choreoathetosis. They did not have other signs of phenytoin intoxication and had complete recovery after phenytoin withdrawal. Phenytoin induced dyskinesia may occur during either chronic or initial treatment and with normal serum phenytoin levels. However, it occurs most often in patients on polytherapy, usually after increasing dosage and with toxic serum levels. Other signs of phenytoin intoxication may be present in these patients, but often the dyskinesia is the only side effect, which may delay the diagnosis and treatment. The clinical characteristics of the involuntary movements vary and may be focal or generalized, most often characterized by choreoathetosis and dyskinesias. These may last for hours, days or even years, but frequently disappear completely after phenytoin withdrawal.</abstract><cop>Brazil</cop><pub>Academia Brasileira de Neurologia - ABNEURO</pub><pmid>10450338</pmid><doi>10.1590/s0004-282x1999000300002</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-282X
ispartof Arquivos de neuro-psiquiatria, 1999-06, Vol.57 (2B), p.356-360
issn 0004-282X
1678-4227
0004-282X
language eng
recordid cdi_scielo_journals_S0004_282X1999000300002
source SciELO Brazil
subjects Anticonvulsants - adverse effects
Child
Child, Preschool
Dyskinesia, Drug-Induced - etiology
Female
Humans
Male
Middle Aged
NEUROSCIENCES
Phenytoin - adverse effects
PSYCHIATRY
title Dyskinesia induced by phenytoin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A06%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-scielo_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dyskinesia%20induced%20by%20phenytoin&rft.jtitle=Arquivos%20de%20neuro-psiquiatria&rft.au=Montenegro,%20M%20A&rft.date=1999-06-01&rft.volume=57&rft.issue=2B&rft.spage=356&rft.epage=360&rft.pages=356-360&rft.issn=0004-282X&rft.eissn=0004-282X&rft_id=info:doi/10.1590/s0004-282x1999000300002&rft_dat=%3Cscielo_cross%3ES0004_282X1999000300002%3C/scielo_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c397t-74db065a00cfb6dbb4ea9f5c88644a817ed791759f0621ff1676c87ae5761e323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10450338&rft_scielo_id=S0004_282X1999000300002&rfr_iscdi=true